Port Wine Stain
16
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
90.0%
+3.5% vs benchmark
0%
0 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
French National Cohort of Children With Port Wine Stain
Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks
Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
Optical Clearing of the Skin in Conjunction With Laser Treatments
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks
The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains
Effect of Laser Treatment on Capillary Malformations
Personalized Interactive Laser Therapy of Port Wine Stain
Optical Frequency Domain Imaging (OFDI) in Dermatology
Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform